Consent of LaBonte & Co. Chartered Accountants for Inclusion of Audit Report in GeneMax Corp. Form 8-K

Summary

LaBonte & Co., Chartered Accountants, consents to the inclusion or incorporation by reference of their audit report on the financial statements of GeneMax Pharmaceuticals Inc. in GeneMax Corp.'s Form 8-K filing with the U.S. Securities and Exchange Commission. This consent allows GeneMax Corp. to use LaBonte & Co.'s audit report as part of its official SEC filing dated September 27, 2002.

Read More Arrow
EX-10.1 3 genemaxex10-1.txt CONSENT EXHIBIT 10.1 LABONTE & CO. 1205 - 1095 West Pender Street - ----------------------------------------- Vancouver, BC Canada C H A R T E R E D A C C O U N T A N T S V6E 2M6 - ----------------------------------------- Telephone ###-###-#### Facsimile ###-###-#### Email: ***@*** September 27, 2002 U.S. Securities and Exchange Commission Division of Corporation Finance 450 Fifth St. N.W. Washington DC 20549 Re: GeneMax Corp. - Form 8-K Current Report Dear Sirs: As chartered accountants, we hereby consent to the inclusion or incorporation by reference in this Form 8-K Current Report Statement dated September 27, 2002, of the following: o Our report to the Stockholders and Board of Directors of GeneMax Pharmaceuticals Inc. (a development stage company), dated July 24, 2002 on the consolidated balance sheets of GeneMax Pharmaceuticals Inc. as at December 31, 2001, 2000 and 1999 and the consolidated statements of operations, stockholders' equity and cash flows for the years ended December 31, 2001 and 2000, for the period from July 27, 1999 (inception) to December 31, 1999 and for the period from July 27, 1999 (inception) to December 31, 2001. Yours truly, /s/ "LaBonte & Co." - ------------------- LABONTE & CO. Chartered Accountants